首页> 外文期刊>Cancer: A Journal of the American Cancer Society >FNA Smears of Pancreatic Ductal Adenocarcinoma Are Superior to Formalin-Fixed Paraffin-Embedded Tissue as a Source of DNA: Comparison of Targeted KRAS Amplification and Genotyping in Matched Preresection and Postresection Samples
【24h】

FNA Smears of Pancreatic Ductal Adenocarcinoma Are Superior to Formalin-Fixed Paraffin-Embedded Tissue as a Source of DNA: Comparison of Targeted KRAS Amplification and Genotyping in Matched Preresection and Postresection Samples

机译:胰腺导管腺癌的FNA涂片优于福尔马林固定的石蜡嵌入组织作为DNA的来源:靶向KRAS扩增和匹配中靶术和POSTresection样品的基因分型比较

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: The current study was conducted to compare DNA yield, including normalization to nuclear area, DNA amplification functionality, and detection of KRAS mutations between matched fine-needle aspiration (FNA) specimens and pancreatic resections diagnostic of pancreatic ductal adenocarcinoma. METHODS: A retrospective sample of 30 matched single FNA smears and macrodissected formalin-fixed, paraffin-embedded (FFPE) curls (2 5-mu m curls) were compared by measuring the following: nuclear area (via digital image analysis), DNA yield (via NanoDrop spectrophotometry and Quantus fluorometry), and polymerase chain reaction threshold cycles for KRAS amplifications. Variants in KRAS codons 12/13 and 61 were detected by fluorescent melt curve analyses, followed by Sanger DNA sequencing. RESULTS: Despite a similar nuclear area, FNA smears yielded greater DNA per nuclear area via 2 DNA quantification methods. KRAS codon 12 mutations were detected in 23 of 30 FNA specimens (77%) compared with 17 of 30 matched FFPE specimens (57%), for a concordance rate of 74%. No KRAS codon 13 or 61 mutations were detected. CONCLUSIONS: FNA specimens are a more optimal source of DNA, and represent an important resource in the preresection and postresection molecular analysis of pancreatic ductal adenocarcinoma. (c) 2017 American Cancer Society.
机译:背景:目前的研究进行了比较DNA产量,包括核面积的归一化,DNA扩增功能和检测匹配的细针抽吸(FNA)标本和胰腺切除术胰腺导管腺癌诊断的KRAS突变。方法:通过测量以下核面积(通过数字图像分析),DNA产量,通过测量核心(通过数字图像分析),DNA产量来比较30种匹配的单个FNA涂片和宏观甲醛固定的石蜡包埋(FFPE)卷曲(2 5-mu m卷曲)(2 5-mu m卷发)。 (通过纳米玻璃分光光度法和量子荧光法),以及用于KRA扩增的聚合酶链反应阈值循环。通过荧光熔体曲线分析检测KRAC密码子12/13和61中的变体,然后检测Sanger DNA测序。结果:尽管具有类似的核面积,但通过2个DNA定量方法,FNA涂片每核面积均产生更大的DNA。与30个FFPE标本(57%)相比,在30个FFN标本(77%)中检测到30个FFPE标本(57%)中检测到克拉斯密码子12突变。检测到kras密码子13或61突变。结论:FNA样本是DNA的更优最佳,并且代表胰腺导管腺癌的校长和POSTrestion分子分析中的重要资源。 (c)2017年美国癌症协会。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号